Therapeutic inhibition of the terminal complement pathway as a disease-modifying treatment for motor neuron disease (2018–2019)

Grant type:
Motor Neurone Disease Research Institute of Australia Inc
Researchers:
Funded by:
Motor Neurone Disease Research Institute of Australia Inc